Recent advances in the treatment of malignant astrocytoma.
about
Chloroquine activates the p53 pathway and induces apoptosis in human glioma cellsO6-Methylguanine DNA methyltransferase protein expression in tumor cells predicts outcome of temozolomide therapy in glioblastoma patientsAn update on vaccine therapy and other immunotherapeutic approaches for glioblastomaEpidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domainIn vitro models of cancer stem cells and clinical applicationsThe future role of personalized medicine in the treatment of glioblastoma multiformePolymerase I and transcript release factor acts as an essential modulator of glioblastoma chemoresistanceA novel small molecule inhibits STAT3 phosphorylation and DNA binding activity and exhibits potent growth suppressive activity in human cancer cells.Cooperativity between MAPK and PI3K signaling activation is required for glioblastoma pathogenesis.Bevacizumab: a treatment option for recurrent glioblastoma multiforme.Glioma angiogenesis: Towards novel RNA therapeutics.Expression of iron-related genes in human brain and brain tumors.Intravoxel water diffusion heterogeneity imaging of human high-grade gliomas.Effect of blood brain barrier permeability in recurrent high grade gliomas on the intratumoral pharmacokinetics of methotrexate: a microdialysis studyMethylation-mediated silencing of microRNA-211 promotes cell growth and epithelial to mesenchymal transition through activation of the AKT/β-catenin pathway in GBMCyclooxygenase-2 is a novel transcriptional target of the nuclear EGFR-STAT3 and EGFRvIII-STAT3 signaling axesIdentification of cell surface glycoprotein markers for glioblastoma-derived stem-like cells using a lectin microarray and LC-MS/MS approach.SUMO1 modification stabilizes CDK6 protein and drives the cell cycle and glioblastoma progression.NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenograftsIntegrated genomic analyses identify ERRFI1 and TACC3 as glioblastoma-targeted genes.A patient with multiple synchronous gliomas of distinctly different grades and correlative radiographic findingsMiR-143 acts as a tumor suppressor by targeting N-RAS and enhances temozolomide-induced apoptosis in glioma.Multifunctional targeting daunorubicin plus quinacrine liposomes, modified by wheat germ agglutinin and tamoxifen, for treating brain glioma and glioma stem cellsBmi-1 promotes the aggressiveness of glioma via activating the NF-kappaB/MMP-9 signaling pathway.An optimized method for manufacturing a clinical scale dendritic cell-based vaccine for the treatment of glioblastoma.MicroRNA-195 inhibits the proliferation of human glioma cells by directly targeting cyclin D1 and cyclin E1.Subsequent neoplasms of the CNS among survivors of childhood cancer: a systematic review.Combined inhibition of AKT/mTOR and MDM2 enhances Glioblastoma Multiforme cell apoptosis and differentiation of cancer stem cells.Imaging, autoradiography, and biodistribution of (188)Re-labeled PEGylated nanoliposome in orthotopic glioma bearing rat model.MicroRNA-30e* promotes human glioma cell invasiveness in an orthotopic xenotransplantation model by disrupting the NF-κB/IκBα negative feedback loop.Alkylpurine-DNA-N-glycosylase confers resistance to temozolomide in xenograft models of glioblastoma multiforme and is associated with poor survival in patientsPCSK9 regulates apoptosis in human neuroglioma u251 cells via mitochondrial signaling pathways.Multiparametric magnetic resonance in the assessment of the gender differences in a high-grade glioma rat modelComprehensive Glycomics of a Multistep Human Brain Tumor Model Reveals Specific Glycosylation Patterns Related to MalignancyHEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity.O6-methylguanine-DNA methyltransferase is downregulated in transformed astrocyte cells: implications for anti-glioma therapies.Genes overexpressed in different human solid cancers exhibit different tissue-specific expression profilesEffect of the JAK2/STAT3 inhibitor SAR317461 on human glioblastoma tumorspheres.A review of VEGF/VEGFR-targeted therapeutics for recurrent glioblastoma.CD90 is identified as a candidate marker for cancer stem cells in primary high-grade gliomas using tissue microarrays
P2860
Q24607826-B5B5B497-990A-4D2F-971C-85BB887E9DAAQ24607903-D2D03ED8-CC03-457E-AC22-4DB84434A096Q27024830-C0285F80-FA32-400B-821D-185CB2C405BCQ27865182-84970CEE-DCA2-428C-83C3-ABB44C866108Q28076101-D1461550-8FF0-4E2F-B412-E16C3DB03759Q28391635-E325A5B8-2E5E-46B9-92FC-4CF55FFE2F6DQ28538029-15BB96A8-C664-470F-A358-47804B1AD007Q30156063-80C7A0FC-F838-4C1E-A1FC-E2FEE87C8985Q30545759-2F257010-B082-4516-902F-A8386B321CE7Q33365902-494648D9-4C87-410C-AB13-5F332FAC7BB4Q33414996-8F690316-B7D2-4EC5-AC8E-2F4BEE0A16B0Q33433700-70FB6F09-EF62-4B1C-B625-164779DB09A1Q33506450-45EF4FD1-E4F6-4464-BD44-1FFCBF8BF3AAQ33642314-A102AE9A-5A2F-451A-926A-370C8A4DCF46Q33648797-83C97A14-0EC0-4664-B371-696979407CCBQ33669979-E250B388-952D-4955-AA15-D4FD51B7D966Q33835228-DF08A8BE-CFF4-464A-B4A1-8C0ABFAA4781Q33876908-7D99EAB2-23A6-4FDB-8001-5A68ED546F59Q33883897-B449DE0A-BD33-4AD3-ACD0-3D05465D3CB7Q34152192-F6686492-0E64-4886-898C-CF5949D06599Q34218198-F75B7F1E-AB6D-40A3-AA7E-00E61C744D96Q34221882-9F7CCA24-1CD1-49F1-A4E0-9063EC98A5E3Q34227784-09A6B3E8-0EE8-45DB-84F9-EB5796644120Q34411179-6E38D896-78C6-4816-9BC7-B3D6F30369D9Q34533616-70B3B75A-3F6D-49EC-8D59-C933AD702EFDQ34575813-9622225C-0939-40E5-9E13-2DEE4A048375Q34788603-F2CDF5F4-9303-42C0-AB69-898EDC06726DQ35505109-0F8174C1-1AAF-446D-8627-6774DE4BCDD2Q35595546-05B1F3C5-4A2A-4503-BAB7-B684CA422541Q35640588-B01D7BCD-4A2C-4FA8-8081-F857BC0D35E2Q35640624-4527B6D2-35A1-4250-9C2B-4E0E36A521C3Q35653477-C522943F-6E8C-4F48-A0C8-A1892108EAEDQ35675400-6C091B74-7A80-455A-B681-26EB417FB6B3Q35679876-0287C2A4-252E-460E-A63D-F81D4F1424B0Q35757997-C839F062-0CC6-41F0-BF39-152FFB33E308Q35844142-1B5D26AF-4F37-4B29-8CCB-6ADFC5964FA0Q35928867-FB992311-3CE5-47F9-B651-8ED3C903DAC8Q35964637-9E8FD34A-7D9B-4CBE-862D-6E88EC3A8ED6Q36103026-3C897C1A-E731-408D-AB60-A7A112D61269Q36209001-63B2247D-C7F3-46B7-86E8-596D6154A614
P2860
Recent advances in the treatment of malignant astrocytoma.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Recent advances in the treatment of malignant astrocytoma.
@ast
Recent advances in the treatment of malignant astrocytoma.
@en
type
label
Recent advances in the treatment of malignant astrocytoma.
@ast
Recent advances in the treatment of malignant astrocytoma.
@en
prefLabel
Recent advances in the treatment of malignant astrocytoma.
@ast
Recent advances in the treatment of malignant astrocytoma.
@en
P50
P356
P1476
Recent advances in the treatment of malignant astrocytoma.
@en
P2093
Jeremy N Rich
P304
P356
10.1200/JCO.2005.04.5302
P407
P577
2006-03-01T00:00:00Z